Normohomocysteinaemia and vitamin‐treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature peripheral arterial occlusive disease. A prospective cohort study

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Internal Medicine

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2796.1999.00541.xPMID 10447230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma Homocysteine and Cardiovascular Disease

  2000cited by this paper
• Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women

  1998cited by this paper
• Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.

  1998cited by this paper
• Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women.

  1998cited by this paper
• Homocysteine, vitamins, and cardiovascular disease.

  1998cited by this paper
• Plasma homocysteine levels and mortality in patients with coronary artery disease.

  1997cited by this paper
• The natural history of vascular disease in homocystinuria and the effects of treatment

  1997cited by this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cited by this paper
• Homocystinuria: what about mild hyperhomocysteinaemia?

  1996cited by this paper
• Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease.

  1996cited by this paper
• Long-term follow-up of patients with early atherosclerosis.

  1996cited by this paper
• Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.

  1996cited by this paper
• Hyperhomocysteinaemia and endothelial dysfunction in young patients with peripheral arterial occlusive disease

  1995cited by this paper
• Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis.

  1995cited by this paper
• Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

  1995cited by this paper
• Three Different Methods for the Determination of Total Homocysteine in Plasma

  1995cited by this paper
• Prevalence of Moderate Hyperhomocysteinemia in Patients with Early-Onset Venous and Arterial Occlusive Disease

  1995cited by this paper
• Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia.

  1994cited by this paper
• Treatment of mild hyperhomocysteinemia in vascular disease patients.

  1994cited by this paper
• Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease.

  1994cited by this paper
• Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function

  1993cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• Mortality over a period of 10 years in patients with peripheral arterial disease.

  1992cited by this paper
• Realistic expectations for the patient with intermittent claudication

  1991cited by this paper
• The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease

  1991cited by this paper
• Hyperhomocysteinemia: an independent risk factor for vascular disease.

  1991cited by this paper
• The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.

  1991cited by this paper
• Disorders of transsulfuration

  1989cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Received

  1868cited by this paper

• B12 and Folic Acid

  2020cites this paper
• Evaluation of Inappropriate Admission and Hospitalization According to Appropriateness Evaluation Protocol and Estimation of Direct Financial Burden

  2019cites this paper
• ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT

  2018cites this paper
• Endothelio- and cardioprotective effects of vitamin В6 and folic acid in modelling methionine-induced hyperhomocysteinemia

  2016cites this paper
• Integrating Complementary Medicine Into Cardiovascular Medicine A

  2016cites this paper
• Effect of non-surgical periodontal therapy on plasma homocysteine levels in Indian population with chronic periodontitis: a pilot study.

  2015cites this paper
• Recruiting older patients with peripheral arterial disease: evaluating challenges and strategies

  2015cites this paper
• Nutritional status and cognitive impairment in elderly.

  2014cites this paper
• Body composition, nutrient intake and MTHFR genotype in patients with peripheral arterial disease

  2014cites this paper
• Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.

  2013cites this paper
• Homocysteine lowering interventions for peripheral arterial disease and bypass grafts.

  2013cites this paper
• The role of nutrition and body composition in peripheral arterial disease

  2012cites this paper
• Nutrition in Severe Dementia

  2012cites this paper
• Tratamento dietético da hiper-homocisteinemia na doença arterial periférica

  2010cites this paper
• Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study

  2009cites this paper
• Hypercoagulability due to homocystinuria in a case of head and neck reconstruction resolved with combined systemic therapy.

  2008cites this paper
• Does nutrition have a role in peripheral vascular disease?

  2006cites this paper
• The role of complementary vitamins, folate, vitamin B6, and vitamin B12, in cardiovascular disease.

  2006cites this paper
• Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine).

  2005cites this paper
• Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases

  2004cites this paper
• Folate and age-related disease

  2004cites this paper
• Hiperhomocisteinemia asociada a mútiples enfermedades, desde la aterotrombosis al Alzheimer: ¿casualidad o causalidad?

  2003cites this paper
• [Homocysteine and alcohol consumption. An ambiguous relationship and a new paradox].

  2003cites this paper
• L’hyperhomocystéinémie : facteur de risque cardiovasculaire ou simple marqueur ? ☆: 2. Données épidémiologiques

  2003cites this paper
• L'hyperhomocystéinémie : facteur de risque cardiovasculaire ou simple marqueur ? 1. Données fondamentales

  2003cites this paper
• [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data].

  2003cites this paper
• Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N‐acetylcysteine therapy

  2003cites this paper
• Indicadores nutricionais e níveis de homocisteína em pacientes com doença arterial periférica

  2002cites this paper
• Homocysteine: An aetiological contributor to peripheral vascular arterial disease

  2002cites this paper
• Folate, Homocysteine, and Cardiovascular Disease

  2002cites this paper
• Mild hyperhomocysteinemia is associated with impaired renal function but not with progression of small abdominal aortic aneurysms

  2002cites this paper
• Homocysteine in myointimal hyperplasia.

  2002cites this paper
• Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease

  2002cites this paper
• Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens

  2002cites this paper
• Dietary modulation of endothelial function: implications for cardiovascular disease.

  2001cites this paper
• Heterogeneity of the Association between Plasma Homocysteine and Atherothrombotic Disease: Insights from Studies of Vascular Structure and Function

  2001cites this paper
• Hyperhomocysteinaemia in patients with peripheral arterial occlusive disease.

  2001cites this paper
• Nutraceuticals: vitamins and other nutrients in coronary heart disease

  2001cites this paper
• Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder.

  2001cites this paper
• Impaired Homocysteine Metabolism and Atherothrombotic Disease

  2001influential citation
• Homocysteine-lowering treatment: an overview

  2001cites this paper
• Hyperhomocysteinaemia in Patients with Peripheral Arterial Occlusive Disease

  2001cites this paper
• Dietary, lifestyle and genetic determinants of homocysteine, and its relation with coronary heart disease

  2001cites this paper
• Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion.

  2000cites this paper
• Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial.

  2000cites this paper
• The controversy over homocysteine and cardiovascular risk.

  2000cites this paper
• Hyperhomocysteinemia in dementia

  2000influential citation
• The effect of different treatment regimens in reducing fasting and postmethionine‐load homocysteine concentrations

  2000cites this paper
• Hyperhomocysteinaemia as a cardiovascular risk factor: an update.

  2000cites this paper
• Homocysteine and its disulfide derivatives: a suggested consensus terminology.

  2000cites this paper
• Normohomocysteinaemia and vitamin-treated hyperhomocysteinaemia are associated with similar risks of cardiovascular events in patients with premature atherothrombotic cerebrovascular disease. A prospective cohort study.

  2000cites this paper
• Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C‐reactive protein in type 2 diabetic and non‐diabetic subjects — The Hoorn Study

  2000cites this paper
• Use of B Vitamins to Reduce Homocysteine in Chronic Mesenteric Ischemia

  2000cites this paper
• The controversy over homocysteine and cardiovascular risk 1,2 Perspective

  2000cites this paper
• A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) Writing Committee Members Task Force Members Vogel Ra. Integrating Complementary Medicine

  year unknowncites this paper